Qatar University and Hamad Medical Corporation

agreement to establish cross-appointed academic clinicians for optimum healthcare delivery in Qatar


Qatar University (QU) signed a unique Memorandum of Understanding (MoU) with Hamad Medical Corporation (HMC) to create a system of cross-appointments.  The agreement was signed by QU President Prof Sheikha Abdulla Al-Misnad and HMC Managing Director DrHanan Al-Kuwari.

These new roles – Corporate Academic Clinicians - will work towards continued improvement in the delivery of quality patient care in Qatar as well as furthering the academic and research objectives of both organizations.

The MoU contributes to the development of a skilled national healthcare workforce and the delivery of safe, high-quality care, in line with Qatar’s National Health Strategy.

Under the terms of the agreement, cross-appointed QU faculty will work closely with HMC clinicians, contributing to patient care – these positions will be in complement to their teaching and research responsibilities at the University.   Reciprocally, cross-appointed clinicians from HMC will engage in teaching and academic activities at the University.

QU’s College of Pharmacy (CPH) is the first of QU colleges to be involved in the new agreement.   Through their appointments as Academic Pharmacy Clinicians, QU faculty members Dr Bridget Javed, Dr Emily Black and Dr Kyle Wilby will bring their expert academic and research capabilities into the clinical setting.

This arrangement will also improve pharmacy teaching, enhance clinical pharmacy practice, and promote engagement in shared research aimed at improving the health and wellbeing of Qatar’s population.  Additional QU colleges are expected to join under the agreement in the coming months.

Commenting on the agreement, Prof Al-Misnad said:  “QU is pleased to again partner with HMC in another important initiative that brings together expertise in research, teaching and clinical practice that will benefit a wide range of stakeholders – the College, HMC, faculty, clinicians, students, patients, and the wider community.   This falls in line with our priority area of Population, Health and Wellness as part of our new 5-year research agenda.   Additionally, it reflects our commitment to serving the needs of the community and to collaborate with like-minded organizations such as HMC to further this objective”.

Dr Al-Kuwari said: “This agreement emphasizes HMC and QU’s joint commitment to advancing the education of health professionals in Qatar, towards fostering a culture of research, and to providing opportunities for continued professional development for our skilled clinical leaders and academic faculty members.   It is an important milestone in HMC’s relationship with QU and in the development of our Academic Health System, and builds upon an already strong foundation between our two organizations”.

CPH Dean DrAyman El-Kadi said:  “This MOU serves to enhance our existing partnership with HMC and allows for a stronger communication flow between both organizations for the benefit of our students’ learning as well as patient care outcomes at HMC hospitals.  It will help us achieve our stated goals and mission as we continue to support the National Health Strategy.  With our talented faculty DrJaved, Dr Black and DrWilby currently serving as cross-appointees, we plan to increase this in the future to cover a diversity of clinical specialties”. 

QU is one of eight partners of a dynamic network comprising HMC, College of North Atlantic-Qatar, Primary Health Care Corporation, Qatar Biomedical Research Institute, University of Calgary-Qatar, Sidra Medical and Research Center, and Weill Cornell Medical College in Qatar in the Academic Health System (AHS) in Qatar.

Academic health systems integrate research, education and clinical care in a unique manner to focus on improving patient care and delivering innovative healthcare solutions. Together, these eight members of the AHS are developing a nationwide academic health system in Qatar -- a first within the MENA region.